Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
When time is of the essence, knowing ways to get emergency cash quickly can make a difference. Explore your options.
23,900 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
When Micron impresses with double-digit growth, it often sets the mood for the broader memory market. This piece brea...
GE Vernova arrives at its July 22 earnings with a $163 billion backlog and raised targets, signaling a strong beat ri...
When a big shareholder starts selling, the market pays attention. This article explains what this major investor dump...
A wave of retirees is piling into ultra-high-yield ETFs, chasing income. Yet by measuring total return after taxes an...
Fort Baker’s decision to liquidate its TGNA position signals shifting beliefs about the media stock. This guide break...
For the first time in decades, Berkshire Hathaway held its annual meeting without Warren Buffett. Executives laid out...
D-Wave Quantum stock is rallying on recent funding news and government support. This guide breaks down what that mean...
A small-cap stock tied to NVIDIA’s AI ecosystem has seen insider purchases surge. Here’s how to interpret the signal,...
NVIDIA CEO Jensen Huang positioned the latest AI stock pullback as a buying opportunity, a stance that reminds invest...
Micron’s stock has surged dramatically in the last year. While some analysts see meaningful upside from current level...
July could bring a fresh wave of stock gains. This article highlights three stocks likely to lead a rally, with clear...